Gabapentin for breast cancer pain
Most women receiving systemic therapy mainly gabapentin for breast cancer, experience hot flashes, a complex symptom that includes a collection of vasomotor symptoms such as a sudden feeling of warmth and redness which begins in the chest and spreads to the neck and face, accompanied by sweating, palpitation and anxiety. To prove the efficacy of gabapentin, a randomised, double-blind, placebo-controlled, multi institutional trial is done to determine the efficacy of gabapentin in controlling hot flashes in women with breast cancer. Results showed that gabapentin is effective in the control of hot flashes at a dose of 900 mg/day, but not at a dose of 300 mg/ day. Therefore, gabapentin should be considered for the treatment of hot flashes in women with breast cancer.